Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT02929498 · TERMINATED
Trial details
- NCT number
- NCT02929498
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2018-01-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.